Key risk factors include delayed childbearing and declining fertility rates, limited access to regular gynecological care and ...

Endometrial cancer is the second most common gynecologic cancer and the sixth most common cancer among women globally. In 2022, ~420,000 cases were diagnosed, which led to ~97,000 deaths worldwide.

Scientists from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, have developed a novel ultrasound-driven therapy that activates dormant cancer drugs directly inside tumors.

References 1. Baranov VS, Osinovskaya NS, Yarmolinskaya MI , Pathogenomics of uterine fibroids development, Int J Mol Sci 20: 6151, 2019. Crossref, Web of Science, Google Scholar; 2. Giuliani E, ...

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S ®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL ...